Details for 2017700748

Up to date per 03.04.2026

Actions

Title / Product Name

6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPIN-DOPAMIN-D3-LIGANDEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017700748

EP Publication Number

3402796

E-Number

1335624

Language

PCT Number

IB17050094

Publication Date

21.11.2018 A

18.11.2020 B1

Registration Date

18.11.2020

AT Publication Date

15.12.2020

Application Date

09.01.2017

Registration Number

Priorities

15.01.2016

201662279037 P

IPC

C07D 471/04 20060101AFI20170809BHEP

Maximum Duration of Protection

09.01.2037

Owner

Pfizer Inc.235 East 42nd Street New York, NY 10017US

Representative

No representatives present

Inventor

CHAPPIE, Thomas Allen59 Hemlock Hill Road Carlisle, Massachusetts 01741US

HENDERSON, Jaclyn Louise36 Highland Avenue Apt. 54 Cambridge, Massachusetts 02139US

YOUNG, Joseph Michael23 Bud Ct Pleasant Hill, CA 94523-3368US

WAGER, Travis T.465 Washington Street Apt. 6 Brookline, Massachusetts 02446US

KORMOS, Bethany Lyn46 Quincy Street 3 Somerville, Massachusetts 02143US

PATEL, Nandini Chaturbhaic/o Pfizer Inc. 610 Main St. Cambridge, MA 02139US

SCIABOLA, Simone109 River Street Cambridge, Massachusetts 02139US

TUTTLE, Jamison Bryce24 Amherst Road Marblehead, Massachusetts 01945US

VERHOEST, Patrick Robert23 Calvin Road Newton, Massachusetts 02460US

TUCKER, Joseph Walter25 Dart Street New London, Connecticut 06320US